Author Correction: Structural and functional evidence that GPR30 is not a direct estrogen receptor

Heng Liu, Shimeng Guo, Antao Dai, Peiyu Xu, Xin Li, Sijie Huang, Xinheng He, Kaichun Wu, Xinyue Zhang, Dehua Yang, Xin Xie, H. Eric XuCell 2025 · DOI · OpenAlex

Introduction

For decades, the scientific community has sought to explain the "rapid" non-genomic effects of estrogen. GPR30 (also known as GPER1) emerged as the leading candidate for a membrane-bound estrogen receptor. However, conflicting reports regarding its ligand specificity have persisted. This study provides definitive structural and functional evidence that estrogen (E2) does not directly bind to or activate GPR30, necessitating a significant re-evaluation of its biological role.

Pharmacological Disproof of Estrogen Binding

To address the controversy, researchers compared the binding affinity and functional activity of estrogen (E2) against classical receptors and GPR30. Using radioligand binding assays, they demonstrated that while E2 binds with high affinity to the nuclear receptor ERα, it shows negligible binding to GPR30.

Pharmacological characterization of GPR30 ligands. Panels (d) and (e) show that E2 fails to bind or trigger signaling through GPR30, unlike the potent activator Lys05.

Functional assays measuring IP-1 accumulation further confirmed these results. While Lys05, a dimeric quinoline compound, acted as a potent agonist, E2 failed to induce any significant signaling response, even at high concentrations. The authors also issued a correction to ensure the chemical identity of the agonist G-1 was accurately represented, reinforcing the reliability of their pharmacological tools.

Structural Basis for Ligand Specificity

The researchers utilized Cryo-Electron Microscopy (Cryo-EM) to solve the atomic structure of GPR30 in complex with the Gq heterotrimer and the ligand Lys05. The resulting model revealed a deep, hydrophobic binding pocket specifically tailored for Lys05.

Structural architecture and mutational analysis of GPR30. The Cryo-EM structure (f-g) and mutational data (i) highlight the specific residues required for ligand-induced activation.

Key residues such as E115, L137, and Q138 were identified as critical for Lys05 binding. Site-directed mutagenesis (e.g., E115A, L137A) completely abolished the receptor's response to Lys05, validating the structural model. Importantly, the geometry and chemical environment of this pocket are incompatible with the steroidal structure of estrogen, providing a physical explanation for the lack of cross-reactivity.

Conclusion and Future Directions

This high-resolution study effectively challenges the classification of GPR30 as an estrogen receptor. By showing that E2 is neither a ligand nor an activator, the research highlights a major gap in our understanding of rapid estrogen signaling. The primary challenge now is to identify the true endogenous ligand for GPR30 and to re-examine the physiological pathways previously attributed to GPR30-mediated estrogenic effects.

Summary updated

BibTeX
@inproceedings{liu2025author,
  author = {Heng Liu and Shimeng Guo and Antao Dai and Peiyu Xu and Xin Li and Sijie Huang and Xinheng He and Kaichun Wu and Xinyue Zhang and Dehua Yang and Xin Xie and H. Eric Xu},
  title = {{Author Correction: Structural and functional evidence that GPR30 is not a direct estrogen receptor}},
  booktitle = {Cell},
  year = {2025},
  doi = {10.1038/s41422-025-01113-8},
}
Figure